Evaluating artificial intelligence (AI) as a clinical decision support tool for lung cancer treatment recommendations.
Roupen Odabashian(Wayne State University), Hirva Mamdani(Wayne State University), Rami Manochakian(Mayo Clinic in Florida), Asmita Shukla(Wayne State University), Suha Soni(The University of Texas at San Antonio Health Science Center), Anastasios Dimou(Mayo Clinic), Aakash Desai(University of Connecticut), Gregory Dyson(The Barbara Ann Karmanos Cancer Institute), Nagasai Yalavarthi(Wayne State University), Jeffrey A. Karson(Syracuse University), Sushmitha Nanja Reddy(The Barbara Ann Karmanos Cancer Institute), Padmapriya Muthu(Mayo Clinic Hospital), Tarik Hadid(Wayne State University)
Cited by 1
Related Papers
Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study
|The Lancet|2020|1.8k
Non–Small Cell Lung Cancer, Version 4.2024
|Journal of the National Comprehensive Cancer Network|2024|746
Chemistry of hot springs on the Mid-Atlantic Ridge
|Nature|1988|444
Immunotherapy in Lung Cancer: Current Landscape and Future Directions
|Frontiers in Immunology|2022|373